Masivet-Boxert.jpg

For Vets only

 

Masivet® treatment has demonstrated a biological response of greater than 79% in dogs with high grade cutaneous or metastatic MCTs

Response rates from 4 clinical studies are summarised below, demonstrating that Masivet® is highly effective in dogs with inoperable Grade 2 and Grade 3 MCTs. In many cases the tumour will disappear completely or significantly reduce in size. In other cases, the rate of tumour progression and spread will be reduced and stabilization of the disease can be achieved for up to 2 years.1,2,3,4,5,6

50% of dogs receiving Masivet® demonstrated a complete response or significant partial response during the first 6 months of therapy (p = 0.02 vs. placebo).1,6